Diana Caridha (researcher)

author (P50)

Q33530732	Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols
Q35081895	Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice
Q33607991	Long-Term Prophylaxis and Pharmacokinetic Evaluation of Intramuscular Nano- and Microparticle Decoquinate in Mice Infected with P. berghei Sporozoites.
Q33526131	Structure-activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum
Q33997571	Structure-activity relationships of 4-position diamine quinoline methanols as intermittent preventative treatment (IPT) against Plasmodium falciparum
Q37485056	Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.
Q36945581	The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
Q64245769	Updating the modified Thompson test by using whole-body bioluminescence imaging to replace traditional efficacy testing in experimental models of murine malaria

Diana Caridha